These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24522928)

  • 1. A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.
    Mire CE; Geisbert JB; Agans KN; Feng YR; Fenton KA; Bossart KN; Yan L; Chan YP; Broder CC; Geisbert TW
    J Virol; 2014 May; 88(9):4624-31. PubMed ID: 24522928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge.
    Pallister J; Middleton D; Wang LF; Klein R; Haining J; Robinson R; Yamada M; White J; Payne J; Feng YR; Chan YP; Broder CC
    Vaccine; 2011 Aug; 29(34):5623-30. PubMed ID: 21689706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdovirus-based vaccine platforms against henipaviruses.
    Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
    J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.
    Pallister JA; Klein R; Arkinstall R; Haining J; Long F; White JR; Payne J; Feng YR; Wang LF; Broder CC; Middleton D
    Virol J; 2013 Jul; 10():237. PubMed ID: 23867060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.
    Bossart KN; Rockx B; Feldmann F; Brining D; Scott D; LaCasse R; Geisbert JB; Feng YR; Chan YP; Hickey AC; Broder CC; Feldmann H; Geisbert TW
    Sci Transl Med; 2012 Aug; 4(146):146ra107. PubMed ID: 22875827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.
    Rockx B; Bossart KN; Feldmann F; Geisbert JB; Hickey AC; Brining D; Callison J; Safronetz D; Marzi A; Kercher L; Long D; Broder CC; Feldmann H; Geisbert TW
    J Virol; 2010 Oct; 84(19):9831-9. PubMed ID: 20660198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats.
    McEachern JA; Bingham J; Crameri G; Green DJ; Hancock TJ; Middleton D; Feng YR; Broder CC; Wang LF; Bossart KN
    Vaccine; 2008 Jul; 26(31):3842-52. PubMed ID: 18556094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
    Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization strategies against henipaviruses.
    Broder CC; Geisbert TW; Xu K; Nikolov DB; Wang LF; Middleton D; Pallister J; Bossart KN
    Curr Top Microbiol Immunol; 2012; 359():197-223. PubMed ID: 22481140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.
    Bossart KN; Geisbert TW; Feldmann H; Zhu Z; Feldmann F; Geisbert JB; Yan L; Feng YR; Brining D; Scott D; Wang Y; Dimitrov AS; Callison J; Chan YP; Hickey AC; Dimitrov DS; Broder CC; Rockx B
    Sci Transl Med; 2011 Oct; 3(105):105ra103. PubMed ID: 22013123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines to Emerging Viruses: Nipah and Hendra.
    Amaya M; Broder CC
    Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A treatment for and vaccine against the deadly Hendra and Nipah viruses.
    Broder CC; Xu K; Nikolov DB; Zhu Z; Dimitrov DS; Middleton D; Pallister J; Geisbert TW; Bossart KN; Wang LF
    Antiviral Res; 2013 Oct; 100(1):8-13. PubMed ID: 23838047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprotection induced by CpG-ODN/Poly(I:C) combined with recombinant gp90 protein in chickens against reticuloendotheliosis virus infection.
    Yuan F; Chu Y; Qi L; Li H; Sun S; Zhao P; Chang S; Guo H
    Antiviral Res; 2017 Nov; 147():1-10. PubMed ID: 28465147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.
    Mire CE; Versteeg KM; Cross RW; Agans KN; Fenton KA; Whitt MA; Geisbert TW
    Virol J; 2013 Dec; 10():353. PubMed ID: 24330654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
    Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
    Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foals of mares vaccinated for Hendra virus have a suboptimal response to HeV vaccination.
    Carey KJ; Smith I; Barr J; Caruso S; Au GG; Hartley CA; Bailey KE; Perriam W; Broder CC; Gilkerson JR
    Vet Microbiol; 2024 Aug; 295():110167. PubMed ID: 38954881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health.
    Middleton D; Pallister J; Klein R; Feng YR; Haining J; Arkinstall R; Frazer L; Huang JA; Edwards N; Wareing M; Elhay M; Hashmi Z; Bingham J; Yamada M; Johnson D; White J; Foord A; Heine HG; Marsh GA; Broder CC; Wang LF
    Emerg Infect Dis; 2014 Mar; 20(3):372-9. PubMed ID: 24572697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.
    Yoneda M; Georges-Courbot MC; Ikeda F; Ishii M; Nagata N; Jacquot F; Raoul H; Sato H; Kai C
    PLoS One; 2013; 8(3):e58414. PubMed ID: 23516477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters.
    Lo MK; Spengler JR; Welch SR; Harmon JR; Coleman-McCray JD; Scholte FEM; Shrivastava-Ranjan P; Montgomery JM; Nichol ST; Weissman D; Spiropoulou CF
    J Infect Dis; 2020 May; 221(Suppl 4):S493-S498. PubMed ID: 31751453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.